• Screen Reader Access
  • A+ A A -
  • A A

2024

7D, a promising antiviral small molecule drug against dengue

Prof. Prasenjit Guchhait’s lab in Regional Centre for Biotechnology, Faridabad, India, has developed a promising antiviral drug for dengue treatment in collaboration with Dr. Shailendra Asthana’s lab in Translational Health Science and Technology Institute, Faridabad. The study was published recently by Gaur KK and Asuru TR et al in the reputed journal EMBO Molecular Medicine.

Nucleolin helps in JEV replication through GQ

Japanese Encephalitis virus (JEV) is endemic in most parts of South-East Asia and the Western Pacific region, causing epidemics of encephalitis with a high case fatality rate. While a tissue culture-derived JEV vaccine is available, no antiviral therapy exists. The JEV NS5 protein has RNA-dependent RNA polymerase activity. Together with several host and viral proteins, it constitutes the replication complex necessary for virus replication. Investigating NS5’s interactions with host proteins offers potential avenues for antiviral development.